As of 2025-09-19, the EV/EBITDA ratio of Homology Medicines Inc (FIXX) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FIXX's latest enterprise value is -6.57 mil USD. FIXX's TTM EBITDA according to its financial statements is -92.11 mil USD. Dividing these 2 quantities gives us the above FIXX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.6x - 11.7x | 8.4x |
| Forward P/E multiples | 7.3x - 16.6x | 12.6x |
| Fair Price | (476.85) - (779.83) | (696.82) |
| Upside | -2042.4% - -3276.5% | -2938.4% |
| Date | EV/EBITDA |